US hospital operator Cedars-Sinai launches Singapore venture unit
Its innovation unit has also entered a co-investment partnership with Enterprise Singapore’s Seeds Capital
Add BT as a preferred sourceSharanya Pillai &
Wu Xinyi
US-BASED healthcare player Cedars-Sinai Medical Centre has launched a new Singapore-based venture unit to invest in early-stage healthcare and biomedical science startups in the country.
Called Coronet Ventures, the unit plans to make equity investments in 12 to 15 Singapore startups over the next five years, with cheque sizes ranging from US$100,000 to US$3 million. It will look at deals in the pre-seed, seed and Series A stages.
“At the moment, we’re looking to focus just on Singapore, and the reason for that is the ecosystem here is very similar, and very synergistic with what we have in the US,” Coronet’s chief executive Nirdesh Gupta told The Business Times in an interview on Thursday (May 25).
TRENDING NOW
Lamborghini-driving boss of Eminent Frog Porridge charged with S$3.8 million tax evasion, money laundering
Not in education, employment or training: Why more Hong Kong youths are opting out of work
With AI, it’s not about coding better; workers need to think better: Koh Boon Hwee
Malaysian tycoon Vincent Tan’s sell-downs point to pruning rather than an exit plan
